You are here: Industry Insights > cancer vaccine

News List

Elios Announces Positive Top-Line Data Evaluating Personalized Therapeutic Cancer Vaccine americanpharmaceuticalreview
July 18, 2019
Elios Therapeutics announced positive top-line results from the Company's prospective, randomized, double-blind, placebo-controlled Phase IIb clinical trial evaluating its lead immuno-oncology candidate, the TLPLDC (tumor lysate ...
Pathogen engineered to self-destruct underlies cancer vaccine platform worldpharmanews
June 27, 2019
A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-destruct once they've done their job, making it safe for use in humans.
First U.S.-Cuba biotech JV to bring Cuban-developed cancer vaccines to the U.S. fiercepharma
November 09, 2018
Three years after the U.S. and Cuba restored their diplomatic relations, the first biotech joint venture between institutions from the two countries has launched with the
Invectys raises €15M series A to fund DNA cancer vaccine study in CLL fiercepharma
November 09, 2018
French startup Invectys hopes its cancer vaccine can win a spot in immuno-oncology combination therapies, and it just nabbed €15 million ($17 million) in series A funding to...
Advaxis cuts staff as it seeks partner for troubled cancer vaccine fiercebiotech
June 11, 2018
Just six weeks after taking the helm of biotech Advaxis, CEO Ken Berlin has launched a search for a partner for its stalled lead axalimogene filolisbac (AXAL) and will scale back trials of the immunotherapy in order to bring earlier stage programs forward
Moderna grabs $125M in expanded Merck cancer vaccine collaboration fiercebiotech
May 07, 2018
On the heels of a massive $500 million round, Moderna has picked up another $125 million in preferred equity as it expands its mRNA cancer vaccine partnership with Merck.
Global Dendritic Cell Cancer Vaccine Market Dosage Price & Clinical Trials Outlook 2024 biospace
March 28, 2018
The "Global Dendritic Cell Cancer Vaccine Market Dosage Price & Clinical Trials Outlook 2024" report has been added to ResearchAndMarkets.com's offering.
Cancer vaccine eliminates tumours europeanpharmaceuticalreview
February 02, 2018
Injecting minute amounts of two immune-stimulating agents directly into solid tumours in mice can eliminate all traces of cancer…
Dendreon touts T-cell response data for prostate cancer vaccine Provenge fiercepharma
June 06, 2017
Years later after 2010, Dendreon has unveiled new data showing the med generates a killer T-cell response—and the strength of that response correlates with overall survival.
Shareholder suit targets NewLink management over failed cancer vaccine trial fiercepharma
May 27, 2017
A year after NewLink Genetics reported a phase 3 trial failure for its pancreatic cancer vaccine that crushed shares, a shareholder is taking it to the company’s current and former execs for “gross mismanagement” and other allegations.

Previous page 1 2 Next page